Hepatocarcinogenetic Studies in Myanmar Thalassemiacs
缅甸地中海贫血患者的肝癌发生研究
基本信息
- 批准号:08042005
- 负责人:
- 金额:$ 5.82万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of the present study is to make the epidemiological survey on the prevalence of iron overload and hepatocellular carcinoma (HCC)among Myanmar population, and clarify the association of iron overload with other factors such as hepatitis B and C virus (HBV and HCV) infection in the development of HCC.The survey was conducted from 24 December 1996 to 7 January 1997, and from 17 to 27 December 1997 at the Department of Medical Research ; the Section of Hepatology and Haematology, Yangon General Hospital ; and the Yangon Children's Hospital. 104 patients including 28 patients of HCC,38 thalassemiacs were surveyed. Their blood was collected with consent from the patients.The results were :l) Hepatitis virus markers : 94% of the liver patients had the past history of HBV infection. Persistent HBV infection was found in 36 patients (35%). HCV-RNA positivity that means persistent HCV infection was 79% among anti-HCV antibody positive patients. 31% of the total patients was suspected to have persistent HCV infection. 46% of HCC was related to HBV only was, 7% to both HBV and HCV,21.4% to HCV.HCV infection were more prevalent among transfuction dependent thalassemiacs. 52% were positive for anti-HCV antibody, and41% are suspected to have persistent HCV infection.2)Iron overload status : Almost all the patients survey had some kind of abnormalities concerning iron metabolism. Two thirds of the hepatology patients showed low TIBC.All the thalassemiacs showed increased transferrin iron saturation and free iron (Gutteridge method).Surprising findings among Myanmar in-patients were the epidemic of hepatitis C virus infection. It is felt imperative to combat the epidemic. Another surprising findings about HCV infection was the identified virus subtype was all lb. Survey system for hepatitis C must be constructed. lron overload found among patients with liver disease must be treated.
本研究的目的是对缅甸人群中铁超载和肝细胞癌(HCC)的患病率进行流行病学调查,并阐明铁超载与其他因素如乙型肝炎(B)和丙型肝炎病毒(HCV)的关系(HBV和HCV)感染在HCC发展中的作用。调查于1996年12月24日至1997年1月7日进行,1997年12月17日至27日,在医学研究部、仰光总医院肝病和血液科和仰光儿童医院。共调查104例患者,其中原发性肝癌28例,地中海贫血38例。结果表明:1)肝炎病毒标志物:94%的肝病患者有HBV感染史。HBV持续感染36例(35%)。抗-HCV抗体阳性患者中HCV-RNA阳性者占79%,表明HCV持续感染。31%的患者怀疑有持续性HCV感染。46%的HCC与HBV有关,7%与HBV和HCV有关,21.4%与HCV有关。抗-HCV抗体阳性率为52%,怀疑HCV持续感染率为41%。2)铁负荷:几乎所有患者都存在某种铁代谢异常。三分之二的肝病患者TIBC较低。所有地中海贫血患者的转铁蛋白铁饱和度和游离铁(Gutteridge法)均升高。人们感到必须防治这一流行病。关于HCV感染的另一个令人惊讶的发现是鉴定的病毒亚型都是lb。必须建立丙型肝炎的监测系统。在肝病患者中发现的铁过载必须治疗。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oda H: "Loss of imprinting of IGF2 in renal-cell carcinomas." Int.J.Cancer.75. 343-348 (1998)
Oda H:“肾细胞癌中 IGF2 印记的丧失。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ehara H.: "Autoclave antigen retrieval technique for immunohistochemical staining of androgen receptor in formalin-fixed paraffin sections." Acta Histochem.Cytochem.29. 311-318 (1996)
Ehara H.:“用于福尔马林固定石蜡切片中雄激素受体免疫组织化学染色的高压灭菌抗原修复技术。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Oda H: "Loss of imprinting of IGF2 in renal-cell carcinomas." Int.J.Cancer. 75. 343-346 (1998)
Oda H:“肾细胞癌中 IGF2 印记的丧失。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Zhang D: "Vitamin E inhibits apoptosis DNA modification and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney." Cancer Res.57. 2410-2414 (1997)
张 D:“维生素 E 抑制 Wistar 大鼠肾脏中铁介导的过氧化诱导的细胞凋亡 DNA 修饰和癌症发生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawabata T: "Iron-induced apoptosis in mouse renal proximal tubules after an injection of a renal carcinogen,iron-nitrilotriacetate." Pathology International. 18. 1389-1394 (1997)
Kawabata T:“注射肾致癌剂次氮基三乙酸铁后,铁诱导小鼠肾近曲小管凋亡。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKADA Shigeru其他文献
OKADA Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKADA Shigeru', 18)}}的其他基金
Studies on the mechanisms for biosynthesis of useful hydrocarbons by a green microalga based on data from EST analyses.
基于 EST 分析数据研究绿色微藻生物合成有用碳氢化合物的机制。
- 批准号:
21380130 - 财政年份:2009
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Preparation of sodium contained aluminum higher borides and a search of higher hardness material
含钠铝高硼化物的制备及高硬度材料的探索
- 批准号:
20560629 - 财政年份:2008
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on enzymes concerned in the biosynthesis of large amounts of useful isoprenoids by a green microalga
绿色微藻生物合成大量有用类异戊二烯所涉及的酶的研究
- 批准号:
18580202 - 财政年份:2006
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on enzyme activities for useful isoprenoid biosynthesis in a microalga.
微藻中有用类异戊二烯生物合成的酶活性研究。
- 批准号:
16580166 - 财政年份:2004
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Membrane damage model of lipid peroxidation, using carboxyfluorescein enveloping liposome
使用羧基荧光素包封脂质体的脂质过氧化膜损伤模型
- 批准号:
04670208 - 财政年份:1992
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Hybrization of deciduous Quercus species in Chugoku Mountain
中国山落叶栎树种的杂交
- 批准号:
04806021 - 财政年份:1992
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
TREATMENT OF WASTE SOLUTIONS BY USE OF ORGANICLIQUIDS PARTIALLY MISCIBLE WITH WATER.
使用与水部分混溶的有机液体处理废物溶液。
- 批准号:
61550462 - 财政年份:1986
- 资助金额:
$ 5.82万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy
用于铁过载治疗的长效、短效纳米螯合剂
- 批准号:
10585319 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Mechanisms of Heme and Non-heme Iron Absorption in Murine Models of Iron Overload
铁过载小鼠模型中血红素和非血红素铁吸收的机制
- 批准号:
10701227 - 财政年份:2022
- 资助金额:
$ 5.82万 - 项目类别:
MODELING MRI-BASED TISSUE RELAXATION IN THE PRESENCE OF IRON OVERLOAD AND STEATOSIS
在存在铁超载和脂肪变性的情况下对基于 MRI 的组织松弛进行建模
- 批准号:
10395564 - 财政年份:2021
- 资助金额:
$ 5.82万 - 项目类别:
MODELING MRI-BASED TISSUE RELAXATION IN THE PRESENCE OF IRON OVERLOAD AND STEATOSIS
在存在铁超载和脂肪变性的情况下对基于 MRI 的组织松弛进行建模
- 批准号:
10196572 - 财政年份:2021
- 资助金额:
$ 5.82万 - 项目类别:
Nanochelation Therapies for Iron Overload Disorders
纳米螯合疗法治疗铁过载疾病
- 批准号:
10437625 - 财政年份:2021
- 资助金额:
$ 5.82万 - 项目类别:
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
QSM 指导铁螯合疗法治疗输血铁过量
- 批准号:
10558645 - 财政年份:2019
- 资助金额:
$ 5.82万 - 项目类别:
Iron Catalyzed H2S and its Prevalence in Hemolytic and Iron Overload Disorders
铁催化的 H2S 及其在溶血和铁过载疾病中的患病率
- 批准号:
10191027 - 财政年份:2019
- 资助金额:
$ 5.82万 - 项目类别:
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
QSM 指导铁螯合疗法治疗输血铁过量
- 批准号:
10337227 - 财政年份:2019
- 资助金额:
$ 5.82万 - 项目类别:
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
QSM 指导铁螯合疗法治疗输血铁过量
- 批准号:
10808000 - 财政年份:2019
- 资助金额:
$ 5.82万 - 项目类别:
Oral Gene Delivery to Improve Iron Overload Disorders
口服基因递送改善铁过载疾病
- 批准号:
9173116 - 财政年份:2016
- 资助金额:
$ 5.82万 - 项目类别: